Breast cancer has also been classified according to their stromal gene profile, which provides additional prognostic information independent of conventional tumor features, such as estrogen receptor (ER) or human epithelial growth factor 2 (Her2/neu) status [4]. This evidence concerns the gene ESR1 and breast carcinoma.